Results 181 to 190 of about 28,066 (219)

PCSK9 promotes atherosclerosis progression through the FOXO3a autophagy signaling pathway. [PDF]

Front Cardiovasc Med
Shi Y, Zhang J, Dai L, Chen J, Geng S, Niu Y, Dong C, Li C, Liu R, Zhao N, Wang X, Gao Z, Yang X, Gao S.   +13 more
europepmc   +1 more source

Correction: A narrative review of PCSK9 inhibitors: from evolocumab to novel discoveries. [PDF]

Front Pharmacol
Liu HH, Li S, Li JJ.
europepmc   +1 more source

Ceramide-Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments. [PDF]

J Cardiovasc Pharmacol
Hilvo M, Witoslawska A, Witoslawska A, Lääperi M, Jylhä A, Lyytikäinen LP, Päivä H, Laurikka J, März W, Karhunen PJ, Lehtimäki T, Laaksonen R.   +11 more
europepmc   +1 more source

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype. [PDF]

Curr Atheroscler Rep
Bourbon M, Alves AC, Chora JR, Hooper AJ, Abifadel M.   +4 more
europepmc   +1 more source

Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity. [PDF]

Mol Ther Nucleic Acids
Osakada Y, Kidawara S, Sakai E, Asayama A, Sakurai F, Shimizu K, Mizuguchi H.   +6 more
europepmc   +1 more source

Enlicitide, a Novel Oral Macrocyclic Peptide PCSK9 Inhibitor for Lipid Lowering: A Systematic Review and Meta-Analysis. [PDF]

J Cardiovasc Dev Dis
Yagmur B, Cekirdekci EI.
europepmc   +1 more source

Evolocumab in the treatment of refractory chylothorax induced by systemic lupus erythematosus complicated with hyperlipidemia: a case report and literature review. [PDF]

Front Immunol
Li X, Li A, Tian M, Chen X, Zhao H, Dai Z, Li J, Li C.   +7 more
europepmc   +1 more source

Mouse Models of Atherosclerosis: What They Teach Us, What They Miss, and When to Use Them. [PDF]

Bioengineering (Basel)
Geng X, McKee AR, Rosa-Garrido M, Cobo I.   +3 more
europepmc   +1 more source

PCSK9 inhibition after heart transplantation: how low does low-density lipoprotein cholesterol need to go for cardiac allograft vasculopathy prevention? [PDF]

J Thorac Dis
Weis M.
europepmc   +1 more source